Company Profile
Bruker Stock Price, News & Analysis
- Ticker:
- BRKR
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
51.27 USD (-2.29%)
Close
Last updated: August 6, 2026
8.72B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, BRKR closed down 2.29% at $51.27. No new same-company headline was identified in the current news window.
Company overview
Scientific Instrumentation
Bruker develops high-performance scientific instruments and analytical solutions used to study life and materials at molecular, cellular and microscopic scales.
Life-Science Research
Its systems support molecular and cell biology, proteomics, multiomics, spatial and single-cell biology, structural biology and preclinical imaging. These tools serve academic, government and biopharmaceutical research laboratories.
Clinical Diagnostics
Bruker provides specialty diagnostic technologies for clinical microbiology, molecular diagnostics and phenomics research, connecting its instrument base with healthcare applications.
Materials and Nanoanalysis
The company also supplies microscopy, spectroscopy and nanoanalysis systems for industrial, energy, clean-technology and advanced-materials research.
Semiconductor Metrology
Bruker's semiconductor tools perform next-generation metrology and process analysis, giving the company exposure to advanced chip manufacturing and infrastructure supporting artificial intelligence.
Future catalysts
Bruker’s catalysts are proteomics and spatial-biology adoption, plus continued demand in analytical instruments. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
- 01
Bruker Reports Second Quarter 2026 Financial Results
Source: Bruker
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Bruker (BRKR)?
Bruker (BRKR) most recently closed at 51.27 USD, a -2.29% move versus the previous session.
What is the market cap of Bruker (BRKR)?
Bruker currently has a market capitalization of 8.72B USD on BioPharmSignal.
What does Bruker do?
Scientific Instrumentation Bruker develops high-performance scientific instruments and analytical solutions used to study life and materials at molecular, cellular and microscopic scales. Life-Science Research Its systems support molecular and cell biology, proteomics, multiomics, spatial and single-cell biology, structural biology and preclinical imaging....
On which exchange is BRKR stock listed?
Bruker (BRKR) is associated with NASDAQ, United States, Biopharma.
What is Scientific?
Scientific Instrumentation Bruker develops high-performance scientific instruments and analytical solutions used to study life and materials at molecular, cellular and microscopic scales.
Which conditions is Bruker targeting with Scientific?
Scientific Instrumentation Bruker develops high-performance scientific instruments and analytical solutions used to study life and materials at molecular, cellular and microscopic scales. Life-Science Research Its systems support molecular and cell biology, proteomics, multiomics, spatial and single-cell biology, structural biology and preclinical imaging....
How does Bruker describe recent progress with Scientific?
Bruker’s catalysts are proteomics and spatial-biology adoption, plus continued demand in analytical instruments. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
What is Instrumentation?
Scientific Instrumentation Bruker develops high-performance scientific instruments and analytical solutions used to study life and materials at molecular, cellular and microscopic scales.